Mirror, mirror on the wall, when are inequalities higher, after all? Analysis of breast and cervical cancer screening in 30 European countries
Bibliographic Data
| ID | 8018396 |
|---|---|
| Authors | Claire Quintal (0000-0002-8306-3431, University of Coimbra), Micaela Antunes (0000-0002-2113-2139, University of Coimbra) |
| Year | 2022 |
| Volume | 312 |
| Pages | 115371-115371 |
| Publication date | 2022-09-15 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Science & Medicine (JOURNAL) |
| Journal identifiers | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2022.115371 |
| PMID | 36137367 |
| OpenAlex | W4295921315 |
| Language | EN |
| Citations received | 4 |
| References cited | 36 |
Screening for breast and cervical cancer is strongly related with a reduction in cancer mortality but previous evidence has found socioeconomic inequalities in screening. Using up-to-date data from the second wave of the European Health Interview Survey (2013-2015), this study aims to analyse income-related inequalities in mammography screening and Pap smear test in 30 European countries. We propose a framework that combines age group and screening interval, identifying situations of due-, under-, and over-screening. Coverage rates, standard and generalised concentration indices are calculated. Overall, pro-rich inequalities in screening persist though there are varied combinations of prevalence of screening attendance and relative inequality across countries. Bulgaria and particularly Romania stand out with low coverage and high inequality. Some Baltic and Mediterranean countries also present less favourable figures on both accounts. In general, there are not marked differences between mammography and Pap smear test, for the recommended situation ('Due-screening'). 'Extreme under-screening' is concentrated among lower income quintiles in basically all countries analysed, for both screenings. These women, who never screened, are at risk of entering the group of 'Lost opportunity', once they reach the upper-limit age of the target group. At the same time, there are signals of 'Over-screening', within target group, due to screening more frequently than recommended. In several countries, 'Over-screening' seems to be concentrated among richer women. This is not only a waste of resources, but it can also cause harms. The inequalities found in 'Extreme under-screening' and 'Over-screening' raise concerns on whether women are making informed choices
Breast cancer · Cancer · Cervical cancer · Gynecology · Inequality · Cervical Cancer and HPV Research · Colorectal Cancer Screening and Detection · Global Cancer Incidence and Screening · Mathematics · Medicine · Internal Medicine
The Co‐Production, Pilot and Qualitative Evaluation of a Cancer Prevention Programme With High‐Risk Women Delivered on Group Walks by Cancer Champions
Exploring Emotional and Cognitive Perceptions of Cervical Cancer Screening and Self‐Sampling Among Vulnerable Romanian Women
Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation
The impact of the Covid-19 pandemic on inequalities in preventive health screenings
Conindex
Estimating the global cancer incidence and mortality in 2018
Income-related inequalities and inequities in health care services utilisation in 18 selected OECD countries
Patient-centred access to health care
Cervical cancer screening programs and their context-dependent effect on inequalities in screening uptake
Wealth-related inequalities of women’s knowledge of cervical cancer screening and service utilisation in 18 resource-constrained countries
Never and under cervical cancer screening in Switzerland and Belgium
Organized screening programmes for breast and cervical cancer in 17 EU countries
Controversies about cervical cancer screening
Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators
Revisiting the Behavioral Model and Access to Medical Care
| Unique citing works | 4 |
|---|---|
| Citations per year | 1,33 |
| Citation span | 2023 - 2025 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |